Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab

Hypohidrotic ectodermal dysplasia (HED) is a rare disease. Patients with HED present with sparse hair on the head, dysplastic teeth and anhidrosis since childhood, along with atopic dermatitis-like skin manifestations. We report a 20-year-old male HED patient with atopic dermatitis-like skin who was...

Full description

Saved in:
Bibliographic Details
Main Authors: Eri Uchiyama, Kiminobu Takeda, Hiroto Ono, Akira Shimizu, Sumihito Togi, Hiroki Ura, Yo Niida
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Journal of Cutaneous Immunology and Allergy
Subjects:
Online Access:https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.13813/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576602063503360
author Eri Uchiyama
Kiminobu Takeda
Hiroto Ono
Akira Shimizu
Sumihito Togi
Hiroki Ura
Yo Niida
author_facet Eri Uchiyama
Kiminobu Takeda
Hiroto Ono
Akira Shimizu
Sumihito Togi
Hiroki Ura
Yo Niida
author_sort Eri Uchiyama
collection DOAJ
description Hypohidrotic ectodermal dysplasia (HED) is a rare disease. Patients with HED present with sparse hair on the head, dysplastic teeth and anhidrosis since childhood, along with atopic dermatitis-like skin manifestations. We report a 20-year-old male HED patient with atopic dermatitis-like skin who was successfully treated with dupilumab. Genetic analysis identified a splicing mutation in the EDA gene, NG_009809.2 (NM_001399.5):c.793 + 3A>C r.742_793del p.Pro248Ilefs Ter15, which has never been reported before. The subject presented to our department because of worsening generalized itching. Based on the distribution of the skin rash, the patient was diagnosed with atopic dermatitis and started on dupilumab. The skin rash became less severe in the third month of treatment. The potential of dupilumab in treating genodermatoses associated with Th2 immunity is known. Although the skin rash is related to atopic dermatitis-like skin manifestations of HED or independent atopic dermatitis is unclear, dupilumab may be a candidate for the treatment of HED with atopic dermatitis skin.
format Article
id doaj-art-27a83e216b8947fbbfa4c946bc914a48
institution Kabale University
issn 2574-4593
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Journal of Cutaneous Immunology and Allergy
spelling doaj-art-27a83e216b8947fbbfa4c946bc914a482025-01-31T04:11:22ZengFrontiers Media S.A.Journal of Cutaneous Immunology and Allergy2574-45932025-01-01810.3389/jcia.2025.1381313813Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumabEri Uchiyama0Kiminobu Takeda1Hiroto Ono2Akira Shimizu3Sumihito Togi4Hiroki Ura5Yo Niida6Department of Dermatology, Kanazawa Medical University, Uchinada, Ishikawa, JapanDepartment of Dermatology, Kanazawa Medical University, Uchinada, Ishikawa, JapanDepartment of Dermatology, Kanazawa Medical University, Uchinada, Ishikawa, JapanDepartment of Dermatology, Kanazawa Medical University, Uchinada, Ishikawa, JapanCenter for Clinical Genomics, Kanazawa Medical University, Uchinada, Ishikawa, JapanCenter for Clinical Genomics, Kanazawa Medical University, Uchinada, Ishikawa, JapanCenter for Clinical Genomics, Kanazawa Medical University, Uchinada, Ishikawa, JapanHypohidrotic ectodermal dysplasia (HED) is a rare disease. Patients with HED present with sparse hair on the head, dysplastic teeth and anhidrosis since childhood, along with atopic dermatitis-like skin manifestations. We report a 20-year-old male HED patient with atopic dermatitis-like skin who was successfully treated with dupilumab. Genetic analysis identified a splicing mutation in the EDA gene, NG_009809.2 (NM_001399.5):c.793 + 3A>C r.742_793del p.Pro248Ilefs Ter15, which has never been reported before. The subject presented to our department because of worsening generalized itching. Based on the distribution of the skin rash, the patient was diagnosed with atopic dermatitis and started on dupilumab. The skin rash became less severe in the third month of treatment. The potential of dupilumab in treating genodermatoses associated with Th2 immunity is known. Although the skin rash is related to atopic dermatitis-like skin manifestations of HED or independent atopic dermatitis is unclear, dupilumab may be a candidate for the treatment of HED with atopic dermatitis skin.https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.13813/fullhypohidrotic ectodermal dysplasia (HED)EDA geneatopic dermatitisdupilumabgenetic analysis
spellingShingle Eri Uchiyama
Kiminobu Takeda
Hiroto Ono
Akira Shimizu
Sumihito Togi
Hiroki Ura
Yo Niida
Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
Journal of Cutaneous Immunology and Allergy
hypohidrotic ectodermal dysplasia (HED)
EDA gene
atopic dermatitis
dupilumab
genetic analysis
title Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
title_full Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
title_fullStr Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
title_full_unstemmed Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
title_short Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
title_sort case report atopic dermatitis like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the eda gene successfully treated with dupilumab
topic hypohidrotic ectodermal dysplasia (HED)
EDA gene
atopic dermatitis
dupilumab
genetic analysis
url https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.13813/full
work_keys_str_mv AT eriuchiyama casereportatopicdermatitislikeskinmanifestationsinhypohidroticectodermaldysplasiacausedbyanovelsplicesitemutationoftheedagenesuccessfullytreatedwithdupilumab
AT kiminobutakeda casereportatopicdermatitislikeskinmanifestationsinhypohidroticectodermaldysplasiacausedbyanovelsplicesitemutationoftheedagenesuccessfullytreatedwithdupilumab
AT hirotoono casereportatopicdermatitislikeskinmanifestationsinhypohidroticectodermaldysplasiacausedbyanovelsplicesitemutationoftheedagenesuccessfullytreatedwithdupilumab
AT akirashimizu casereportatopicdermatitislikeskinmanifestationsinhypohidroticectodermaldysplasiacausedbyanovelsplicesitemutationoftheedagenesuccessfullytreatedwithdupilumab
AT sumihitotogi casereportatopicdermatitislikeskinmanifestationsinhypohidroticectodermaldysplasiacausedbyanovelsplicesitemutationoftheedagenesuccessfullytreatedwithdupilumab
AT hirokiura casereportatopicdermatitislikeskinmanifestationsinhypohidroticectodermaldysplasiacausedbyanovelsplicesitemutationoftheedagenesuccessfullytreatedwithdupilumab
AT yoniida casereportatopicdermatitislikeskinmanifestationsinhypohidroticectodermaldysplasiacausedbyanovelsplicesitemutationoftheedagenesuccessfullytreatedwithdupilumab